<DOC>
	<DOCNO>NCT02532907</DOCNO>
	<brief_summary>This study design obtain store sample serum liver tissue HCV ( HepC Virus ) -infected patient treat direct-acting antiviral ( DAA ) therapy , determine effect new DAA therapy HCV-related response liver peripheral blood . The introduction new DAAs regimens include IFN provide unique novel opportunity examine whether successful treatment-induced eradication viral antigen result reconstitution T cell immunity . serum liver tissue sample collect stored hope improve treatment outcome future patient .</brief_summary>
	<brief_title>Study Hepatic Responses Patients Receiving Direct-acting Anti-HCV Drugs</brief_title>
	<detailed_description>This study design obtain store sample serum liver tissue HCV-infected patient treat DAA therapy . A liver biopsy perform pre-treatment research reason . A small liver sample require pathologic analysis also store . Patients undergo another liver biopsy either 4 12 week initiation DAA therapy . Any patient HCV-related liver disease ( age &gt; 18 ) consider study . Patients 120 ml blood draw research purpose baseline 12 week stop DAA treatment along 60 ml blood draw 2 , 4 , 8 , 12 week treatment . The liver biopsy baseline either 4 12 week examine use molecular technique measure transcription key gene involve antiviral response .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Inclusion Criteria Signed inform consent Ages 1870 HCVinfected patient treat directacting antiviral ( DAA ) therapy . Exclusion Criteria Pregnant woman females childbearing potential contraception Institutionalized mentally disable person Prisoners Unwilling unable provide inform consent Subjects HIV positive Anticipated inability follow Chronic anemia Platelet count &lt; 100 liver biopsy patient document fatty liver disease ultrasound prior enrollment Any patient bleeding disorder prolong INR Abstinent consume less two drink alcohol per day . Clinical hepatic decompensation ( i.e. , ascites , encephalopathy variceal hemorrhage ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>HCV</keyword>
</DOC>